A detailed history of Russell Investments Group, Ltd. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 13,823 shares of ARDX stock, worth $65,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,823
Previous 212,444 93.49%
Holding current value
$65,244
Previous $1.57 Million 93.96%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.28 - $7.57 $1.05 Million - $1.5 Million
-198,621 Reduced 93.49%
13,823 $95,000
Q2 2024

Aug 08, 2024

SELL
$5.89 - $9.31 $1.91 Million - $3.02 Million
-323,853 Reduced 60.39%
212,444 $1.57 Million
Q1 2024

May 08, 2024

BUY
$6.05 - $9.74 $1.63 Million - $2.62 Million
269,046 Added 100.67%
536,297 $3.91 Million
Q4 2023

Feb 05, 2024

BUY
$3.29 - $6.64 $879,032 - $1.77 Million
267,183 Added 392916.19%
267,251 $1.66 Million
Q3 2023

Nov 13, 2023

BUY
$3.3 - $4.83 $224 - $328
68 New
68 $0
Q1 2022

May 05, 2022

SELL
$0.65 - $1.18 $31,210 - $56,658
-48,016 Closed
0 $0
Q4 2021

Jan 21, 2022

SELL
$0.86 - $1.7 $13,766 - $27,213
-16,008 Reduced 25.0%
48,016 $52,000
Q3 2021

Nov 08, 2021

SELL
$1.27 - $8.17 $1,233 - $7,933
-971 Reduced 1.49%
64,024 $84,000
Q2 2021

Aug 04, 2021

SELL
$6.55 - $8.98 $49,249 - $67,520
-7,519 Reduced 10.37%
64,995 $491,000
Q1 2021

May 10, 2021

SELL
$6.1 - $7.69 $193,437 - $243,857
-31,711 Reduced 30.43%
72,514 $478,000
Q4 2020

Feb 08, 2021

BUY
$5.05 - $7.1 $526,336 - $739,997
104,225 New
104,225 $673,000
Q4 2018

Feb 11, 2019

SELL
$1.66 - $4.16 $20,584 - $51,584
-12,400 Closed
0 $0
Q3 2018

Oct 26, 2018

SELL
$3.75 - $4.65 $2,250 - $2,790
-600 Reduced 4.62%
12,400 $53,000
Q2 2018

Aug 08, 2018

SELL
$3.7 - $5.8 $4,440 - $6,960
-1,200 Reduced 8.45%
13,000 $49,000
Q4 2017

Feb 06, 2018

BUY
$4.85 - $7.8 $68,870 - $110,760
14,200
14,200 $95,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $730M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.